Immunotherapy for T-Cell ALL and T-NHL: Highlights From SOHO 2020

Allyson Price

首页> 外文期刊>Journal of the advanced practitioner in oncology >Immunotherapy for T-Cell ALL and T-NHL: Highlights From SOHO 2020

【24h】

Immunotherapy for T-Cell ALL and T-NHL: Highlights From SOHO 2020

机译：T-Cell All和T-NHL的免疫疗法：来自SOHO 2020的亮点

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

In his keynote presentation, Dr. DiPersio provided hope for the use of immunotherapy in patients with T-cell malignancies, including T-cell acute lymphoblastic leukemia (ALL) and T-cell non-Hodgkin lymphoma (T-NHL), despite the complexity of the diseases such as complex karyotype, early phenotype, and specific mutations (lack of NOTCH mutations, presence of RAS mutations). When patients relapse with these diseases, they have worse outcomes or poor prognosis.

机译：在他的主题演讲中，迪佩西奥博士为T细胞恶性肿瘤患者的免疫治疗带来了希望，包括T细胞急性淋巴细胞白血病（ALL）和T细胞非霍奇金淋巴瘤（T-NHL），尽管疾病复杂，如复杂的核型、早期表型和特异性突变（缺乏NOTCH突变、存在RAS突变）。当患者因这些疾病复发时，他们的预后会更差。

著录项

来源
《Journal of the advanced practitioner in oncology》 |2021年第1期|共2页
作者
Allyson Price;
展开▼
作者单位

The University of Texas MD Anderson Cancer Center;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Updating targets for natural killer/T-cell lymphoma immunotherapy [J] . Weili Xue, Mingzhi Zhang 癌症生物学与医学（英文版） . 2021,第001期
2. Updating targets for natural killer/T-cell lymphoma immunotherapy [J] . Weili Xue, Mingzhi Zhang 癌症生物学与医学：英文版 . 2021,第001期
3. Managing Relapsed Disease in Peripheral T-Cell Lymphoma: Highlights From SOHO 2020 [J] . Kelly Valla Journal of the advanced practitioner in oncology . 2021,第Suppla1期

机译：在外周T细胞淋巴瘤中进行复发疾病：来自SOHO 2020的亮点
4. Emerging Therapies in Myelofibrosis: Highlights From SOHO 2020 [J] . Lisa Nodzon Journal of the advanced practitioner in oncology . 2021,第Suppla1期

机译：新兴疗法在肌电纤维化中：Soho 2020的亮点
5. Updates on Therapeutic Advancements in Relapsed or Refractory Multiple Myeloma: Highlights From SOHO 2020 [J] . Lisa Nodzon Journal of the advanced practitioner in oncology . 2021,第Suppla1期

机译：复发或难治性多发性骨髓瘤的治疗进步的更新：来自SOHO 2020的亮点
6. Engineered T-cell cancer immunotherapy tracking with x-ray computed tomography [C] . Johoon Kim, Peter Chhour, Alexander Silva, Society for Biomaterials annual meeting and exposition . 2018

机译：用X射线计算机断层扫描追踪工程化T细胞癌症免疫疗法
7. Carbohydrate derived nanoplatforms as tools for lectin isolation, and delivery of cytotoxic T-cell peptide epitopes for cytotoxic T-cell mediated tumor immunotherapy. [D] . Kavunja, Herbert Wanjala. 2015

机译：碳水化合物衍生的纳米平台作为凝集素分离的工具，以及细胞毒性T细胞肽表位的递送，用于细胞毒性T细胞介导的肿瘤免疫治疗。
8. Immunotherapy for T-Cell ALL and T-NHL: Highlights From SOHO 2020 [O] . 2021

机译：T-Cell All和T-NHL的免疫疗法：来自SOHO 2020的亮点
9. Comparison of High-Dose Gemcitabine, Busulfan and Melphalan (GEM/BU/MEL) and BEAM in Concurrent Patient Cohorts with Mature T-CELL NON-Hodgkin's Lymphoma (T-NHL) Receiving an Autologous Stem Cell Transplantation (ASCT) [O] . Yago Nieto, Roland Bassett, Chitra Hosing, 2016

机译：高剂量吉西他滨，伯林和梅酚（宝石/梅兰（Gem / Bu / Mel）和梁在同时患者群中的成熟T细胞非霍奇金淋巴瘤（T-NHL）接受自体干细胞移植（ASCT）
10. Enhancing the Efficacy of Prostate Cancer Immunotherapy by Manipulating T-Cell Receptor Signaling in Order to Alter Peripheral Regulatory T-Cell Activity [R] . Gray, A. 2011

机译：通过操纵T细胞受体信号增强前列腺癌免疫治疗的功效，以改变外周调节性T细胞活性

Immunotherapy for T-Cell ALL and T-NHL: Highlights From SOHO 2020

摘要

著录项

相似文献

相关主题

期刊订阅